Atsushi Masamune, Takashi Watanabe, Kazuhiro Kikuta, Tooru Shimosegawa 

Slides:



Advertisements
Similar presentations
Don C. Rockey  Clinical Gastroenterology and Hepatology 
Advertisements

Continuous Delivery of Neutralizing Antibodies Elevate CCL2 Levels in Mice Bearing MCF10CA1d Breast Tumor Xenografts  Min Yao, Curtis Smart, Qingting.
Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Induce Expression of CXCR4 on Human Endothelial Cells  Rosalba Salcedo, Ken Wasserman,
Volume 139, Issue 3, Pages e8 (September 2010)
Secretagogues cause ubiquitination and down-regulation of inositol 1,4,5-trisphosphate receptors in rat pancreatic acinar cells  Richard J.H. Wojcikiewicz*,
Volume 17, Issue 5, Pages (May 2015)
Connective Tissue Growth Factor (CCN2) in Rat Pancreatic Stellate Cell Function: Integrin α5β1 as a Novel CCN2 Receptor  Runping Gao, David R. Brigstock 
Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells  G-One Ahn,
Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension  Robert B. Good, Adrian J. Gilbane, Sarah.
Volume 136, Issue 2, Pages e5 (February 2009)
The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis  Rana Herro, Ricardo Da S. Antunes, Amelia R. Aguilera,
Mesenchymal Stem Cells Promote Formation of Colorectal Tumors in Mice
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Volume 131, Issue 3, Pages (September 2006)
Tocotrienols Induce Apoptosis and Autophagy in Rat Pancreatic Stellate Cells Through the Mitochondrial Death Pathway  Mariana Rickmann, Eva C. Vaquero,
Volume 134, Issue 7, Pages (June 2008)
Don C. Rockey  Clinical Gastroenterology and Hepatology 
Daniel K. Podolsky, Guido Gerken, Annette Eyking, Elke Cario 
Volume 133, Issue 2, Pages (August 2007)
Volume 142, Issue 4, Pages e3 (April 2012)
Epstein–Barr Virus Infection Induces Aberrant TLR Activation Pathway and Fibroblast– Myofibroblast Conversion in Scleroderma  Antonella Farina, Mara Cirone,
Volume 143, Issue 1, Pages e7 (July 2012)
Chronic Pancreatitis and Pancreatic Cancer: Prediction and Mechanism
Volume 74, Issue 7, Pages (October 2008)
Volume 139, Issue 3, Pages (September 2010)
Mechanisms of Hepatic Fibrogenesis
Desmoplasia of Pancreatic Ductal Adenocarcinoma
Volume 128, Issue 4, Pages (April 2005)
Volume 137, Issue 4, Pages e5 (October 2009)
Regulation of Human Melanoma Growth and Metastasis by AGE–AGE Receptor Interactions  Riichiro Abe, Tadamichi Shimizu, Hiroshi Sugawara, Hirokazu Watanabe,
Volume 11, Issue 2, Pages (February 2005)
Volume 143, Issue 1, Pages e7 (July 2012)
Aravind Sugumar, Suresh T. Chari 
Volume 128, Issue 5, Pages (May 2005)
Volume 139, Issue 3, Pages e8 (September 2010)
Volume 9, Issue 1, Pages (January 2006)
Mesenchymal Stem Cells Promote Formation of Colorectal Tumors in Mice
Volume 124, Issue 3, Pages (March 2003)
Manuela Schmidt, Danny Gutknecht, Jan C
Protease-Activated Receptor-2 (PAR-2) Expression in Human Fibroblasts is Regulated by Growth Factors and Extracellular Matrix  Barry L. Gruber, Mary J.
Volume 25, Issue 11, Pages (November 2017)
Volume 134, Issue 3, Pages (March 2008)
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Volume 146, Issue 5, Pages (May 2014)
Volume 132, Issue 5, Pages (May 2007)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 134, Issue 1, Pages (January 2008)
Thrombosis and Inflammatory Bowel Disease
New Models of Gastroenterology Practice
Volume 22, Issue 4, Pages (April 2014)
Sustained Activation of Fibroblast Transforming Growth Factor-β/Smad Signaling in a Murine Model of Scleroderma  Shinsuke Takagawa, Gabriella Lakos, Yasuji.
Volume 144, Issue 3, Pages (March 2013)
Extracellular Adherence Protein of Staphylococcus aureus Suppresses Disease by Inhibiting T-Cell Recruitment in a Mouse Model of Psoriasis  Honglin Wang,
Volume 137, Issue 5, Pages (November 2009)
Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells  G-One Ahn,
Connective Tissue Growth Factor (CCN2) in Rat Pancreatic Stellate Cell Function: Integrin α5β1 as a Novel CCN2 Receptor  Runping Gao, David R. Brigstock 
Volume 15, Issue 1, Pages (January 2009)
Volume 123, Issue 6, Pages (December 2002)
Volume 6, Issue 4, Pages (October 2004)
James Gailit, Mary J. Marchese, Richard R. Kew, Barry L. Gruber 
Synthesis of Collagen I in Collagenous Sprue
Volume 19, Issue 6, Pages (June 2011)
Molecular Therapy - Nucleic Acids
Pregnancy and breast cancer: The other side of the coin
Morphologic changes induced in immortalized human podocytes after treatment with TGF-β1 (10 ng/mL, right) for 3 days when compared with control cells (left),
Yoshinori Aragane, Akira Maeda, Chang-Yi Cui, Tadashi Tezuka 
Gemcitabine-Incorporated G-Quadruplex Aptamer for Targeted Drug Delivery into Pancreas Cancer  Jun Young Park, Ye Lim Cho, Ju Ri Chae, Sung Hwan Moon,
N-3 PUFAs promote endometrial cancer cell apoptosis in vitro and in vivo. n-3 PUFAs promote endometrial cancer cell apoptosis in vitro and in vivo. HEC-1-A.
Targeting GAPLINC decreased CD44 expression and tumor growth in vivo.
Presentation transcript:

Roles of Pancreatic Stellate Cells in Pancreatic Inflammation and Fibrosis  Atsushi Masamune, Takashi Watanabe, Kazuhiro Kikuta, Tooru Shimosegawa  Clinical Gastroenterology and Hepatology  Volume 7, Issue 11, Pages S48-S54 (November 2009) DOI: 10.1016/j.cgh.2009.07.038 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Stimulants of PSC activation. Quiescent PSCs undergo morphologic and functional changes to become activated myofibroblast-like cells. In vitro studies have identified a variety of soluble factors such as cytokines and growth factors, ethanol and its metabolites, oxidative stress, and pressure, as well as extensive changes in the composition and organization of ECM, as regulators of PSC activation. During pancreatic injury, inflammation, and pancreatic cancer in vivo, PSCs are likely to be exposed to these stimuli. Clinical Gastroenterology and Hepatology 2009 7, S48-S54DOI: (10.1016/j.cgh.2009.07.038) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Conditioned media of hypoxia-treated PSCs induced angiogenesis in vitro and in vivo. (A) Human umbilical vein endothelial cells (HUVECs) were added to each well onto solidified ECM gel in 600 μL of serum-free medium or of conditioned media of hypoxia-treated PSCs (PSC-CM). After 18-hour incubation, endothelial cell tube formation was assessed under light microscopy. Original magnification, ×4 objective. (B) Pre-chilled, semi-closed silicone cylinders (angioreactors) were filled with 20 μL of a basement membrane extract premixed with a control serum-free medium or 10-fold concentrated conditioned media from hypoxia-treated PSCs. After forming a gel, angioreactors were implanted subcutaneously in the dorsal flanks of nude mice. After 14 days, angioreactors were removed from mice, and vessel formation was assessed. Arrows indicate the direction of vessel formation. Clinical Gastroenterology and Hepatology 2009 7, S48-S54DOI: (10.1016/j.cgh.2009.07.038) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 Postactivation events. After initiation of activation, PSCs might have 2 fates. If inflammation and injury are sustained or repeated, PSC activation is perpetuated, leading to development of pancreatic fibrosis. However, if inflammation and injury are limited, PSCs might undergo apoptosis or revert to quiescent stage. In the latter scenario, fibrosis will not develop. Clinical Gastroenterology and Hepatology 2009 7, S48-S54DOI: (10.1016/j.cgh.2009.07.038) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 Interactions between PSCs and cancer cells promote progression of pancreatic cancer. In vitro studies have shown that conditioned media of pancreatic cancer cells induced proliferation, production, and degradation of ECM and angiogenesis in PSCs, at least in part through PDGF, TGF, and fibroblast growth factor-2. Conversely, conditioned media of PSCs stimulated cancer cell proliferation and migration and protected them from radiation and gemcitabine-induced apoptosis, in part through the action of PDGF. In addition, PSCs can create a tumor-supportive microenvironment enriched with matricellular proteins that include periostin, galectins, connective tissue growth factor, cysteine-rich acidic secreted protein, and fibrinogen. Clinical Gastroenterology and Hepatology 2009 7, S48-S54DOI: (10.1016/j.cgh.2009.07.038) Copyright © 2009 AGA Institute Terms and Conditions

Figure 5 PSCs support the growth of cancer cells in vivo. PC-1 pancreatic cancer cells were injected subcutaneously into nude mice either alone (left side of the back) or together with PSCs (right side). After 4 weeks, the size of subcutaneous tumor was greater if PSCs were injected together with cancer cells (right side) (unpublished observations: Masamune A, et al). Clinical Gastroenterology and Hepatology 2009 7, S48-S54DOI: (10.1016/j.cgh.2009.07.038) Copyright © 2009 AGA Institute Terms and Conditions

Figure 6 BM-derived cells contributed to the population of activated PSCs in pancreatic fibrosis in mice. Eight weeks after cross-gender BM transplantation, CP was induced by 6 intra-abdominal injections of cerulein at 1-hour intervals, 3 days each week, for total of 6 weeks in recipient female mice. The pancreata were removed 6 weeks after the beginning of cerulein treatment. Immunofluorescent staining for α-SMA (shown in red) was performed, along with fluorescence in situ hybridization for the Y chromosome. Nuclei were counterstained with DAPI (blue). Arrows indicate representative α-SMA+/Y+ cells. Original magnification, ×400 (unpublished observations: Watanabe T, et al). Clinical Gastroenterology and Hepatology 2009 7, S48-S54DOI: (10.1016/j.cgh.2009.07.038) Copyright © 2009 AGA Institute Terms and Conditions